P500 Post-marketing safety experience of vedolizumab in patients receiving concomitant treatment with other biologics
| Main Authors: | , , , |
|---|---|
| Format: | Conference item |
| Published: |
Oxford University Press
2019
|
| Main Authors: | , , , |
|---|---|
| Format: | Conference item |
| Published: |
Oxford University Press
2019
|